DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in access to its products for those treating ...
Dexcom announces the FDA approval of its over-the-counter glucose monitor, which will provide access to new medical resources for those lacking insurance. For those diagnosed with Type 2 Diabetes, a ...
March 24--Shares of DexCom gained more than 8 percent Friday after Medicare issued a favorable ruling for reimbursing use of continuous glucose monitors, made by the San Diego-based company. DexCom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results